96 filings
ARS
2023 FY
VERA
Vera Therapeutics Inc - Ordinary Shares
3 Apr 24
Annual report to shareholders
9:55pm
DEFA14A
VERA
Vera Therapeutics Inc - Ordinary Shares
3 Apr 24
Additional proxy soliciting materials
5:02pm
S-8
VERA
Vera Therapeutics Inc - Ordinary Shares
27 Mar 24
Registration of securities for employees
4:16pm
8-K
4kb8uvq
20 Mar 24
Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
7:30am
8-K
shmn 8fawlp
30 Jan 24
Other Events
4:54pm
424B5
ujdc6oyx6j8
30 Jan 24
Prospectus supplement for primary offering
4:52pm
S-3MEF
fbx00
29 Jan 24
Registration of additional securities for an S-3
9:58pm
424B5
w1ycyywuz p9
29 Jan 24
Prospectus supplement for primary offering
8:46am
8-K
39ux3
29 Jan 24
Results of Operations and Financial Condition
6:05am
8-K
mluzpzyg
25 Jan 24
Vera Therapeutics Presents Positive 72-Week Data Showing eGFR Stabilization in the Phase 2b ORIGIN Clinical Trial OLE in IgA Nephropathy
6:31am
8-K
1u95 0v7b752p4bmj
8 Jan 24
Departure of Directors or Certain Officers
8:05am
8-K
y6kmo0cl84g48697
8 Jan 24
Regulation FD Disclosure
8:03am
8-K
g8nfp99ovxpx1i8 7s3
26 Dec 23
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4:02pm
8-K
upe7 cfhf
9 Nov 23
Vera Therapeutics Provides Business Update and Reports Third Quarter Financial Results
8:00am
8-K
j6sotn1i 2ec
10 Aug 23
Vera Therapeutics Provides Business Update and Reports Second Quarter Financial Results
8:01am
8-K
p834ul
20 Jun 23
Regulation FD Disclosure
7:50am